X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

CURRENT OPINION IN CELL BIOLOGY

期刊標題檢索 CURR OPIN CELL 最新評論: It is recommended to complete the main body results section before sta... (2021-12-30)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[CURRENT OPINION IN CELL BIOLOGY]您好,您是該頁面的第 30755 位訪客。

期刊簡介
期刊名稱CURRENT OPINION IN CELL BIOLOGY CURRENT OPINION IN CELL BIOLOGY
LetPub Score
8.0
50 ratings
Rate

Reputation
8.8

Influence
7.2

Speed
8.8

期刊簡稱CURR OPIN CELL BIOL
ISSN0955-0674
E-ISSN1879-0410
h-index242
CiteScore
CiteScoreSJRSNIPCiteScore Rank
14.603.5591.422
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cell Biology
Q133 / 285

自引率 (2023-2024)1.70%自引率趨勢
掲載範囲
Current Opinion in Cell Biology (COCEBI) publishes authoritative, comprehensive, and systematic reviews. COCEBI helps specialists keep up to date with a clear and readable synthesis on current advances cell biology. Expert authors annotate the most interesting papers from the expanding volume of information published today, saving valuable time and giving the reader insight on areas of importance.

Current Opinion in Cell Biology is part of the Current Opinion and Research (CO+RE) suite of journals and is a companion to the new primary research, open access journal, Current Research in Cell Biology (CRCBIO). CO+RE journals leverage the Current Opinion legacy—of editorial excellence, high-impact, and global reach—to ensure they are a widely read resource that is integral to scientists’ workflow.

Current Opinion in Cell Biology serves as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. The subject of cell biology is divided into six themed sections, each of which is reviewed once a year. Themes include cell architecture; cell signaling; cell nucleus; membrane trafficking; cell dynamics; and cell differentiation and disease.
官方網站http://www.journals.elsevier.com/current-opinion-in-cell-biology/
在線稿件提交https://www.editorialmanager.com/COCEBI
開放訪問No
出版商Elsevier Ltd
主題領域生物
出版國/地區ENGLAND
發行頻率隔月刊行
創刊年1989
每年文章數103每年文章數趨勢
黃金OA百分比45.13%
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ151/205
索引 (SCI or SCIE)Science Citation Index
Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0955-0674%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: Sort of slow, 4-8 Week(s)
競爭力 *來自作者的數據: Very difficult
參考鏈接
相關期刊 【CURRENT OPINION IN CELL BIOLOGY】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    NATURE REVIEWS MOLECULAR CELL BIOLOGYH-index: 386

    CiteScore: 173.60
    CELL RESEARCHH-index: 143

    CiteScore: 53.90
    Cell Stem CellH-index: 212

    CiteScore: 37.10
    NATURE CELL BIOLOGYH-index: 337

    CiteScore: 28.40
    AutophagyH-index: 121

    CiteScore: 21.30
    TRENDS IN CELL BIOLOGYH-index: 215

    CiteScore: 32.00
    JOURNAL OF CELL BIOLOGYH-index: 353

    CiteScore: 12.60
    CELL PROLIFERATIONH-index: 66

    CiteScore: 14.80
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGYH-index: 142

    CiteScore: 10.70
    EUROPEAN JOURNAL OF CELL BIOLOGYH-index: 87

    CiteScore: 7.30
    學科內最受檢索的期刊 頁面查看次數
    Oxidative Medicine and Cellular Longevity251304
    CELL RESEARCH238017
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE184591
    BIOSCIENCE REPORTS161837
    Autophagy154876
    CELL PROLIFERATION138040
    EXPERIMENTAL CELL RESEARCH136411
    NATURE CELL BIOLOGY127900
    MOLECULAR AND CELLULAR BIOCHEMISTRY116485
    PLANT AND CELL PHYSIOLOGY114911
  •  

    CURRENT OPINION IN CELL BIOLOGY CURRENT OPINION IN CELL BIOLOGY
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    下一頁    末頁  (頁
/1)
  [CURRENT OPINION IN CELL BIOLOGY] 的評論撰寫評論
作者: 维尔娜菲茨杰拉德


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 23:00:02 評論於
It is recommended to complete the main body results section before starting to write the article. Alternatively, you could start brainstorming the article after obtaining the main phenotypic data or designing the study, and then write as you go
(0) 讚! | 维尔娜菲茨杰拉德

作者: 维尔娜菲茨杰拉德


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-30 17:41:09 評論於
This varies from person to person. If the main results have been completed, it is generally recommended to start with the results first. If the main results are still in progress, you can start with the methods and introduction
(0) 讚! | 维尔娜菲茨杰拉德

作者: 深渊兴业


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-27 12:43:27 評論於
What is the general writing sequence of a research article?
(0) 讚! | 深渊兴业

作者: 修然小公主


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2021-12-26 21:48:16 評論於
At what stage of the experiment is it appropriate to start writing the paper?
(0) 讚! | 修然小公主

作者: 重阳文景


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-02 18:14:20 評論於
Has no one ever submitted to this magazine? Why are there no comments?
(0) 讚! | 重阳文景

作者: 重阳文景


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2019-03-02 10:11:04 評論於
Who knows what constitutes a sub-journal of cells?
(0) 讚! | 重阳文景

作者: Happy


領域: 生物
審稿時間: 4.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-19 11:51:48 評論於
This is a top journal in cell biology. My advisor loves this journal – he always recommends this journal for submission.

(0) 讚! | Happy

作者: 和顺超级甜


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2018-10-19 10:54:25 評論於
Review speed: 2.0 Experience sharing: The boss has always wanted to publish an article in a top journal of cell biology, but has never succeeded. This year, he asked me to submit one, and I feel that the hope is slim
(0) 讚! | 和顺超级甜

作者: 凌霄高洁


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2017-07-16 21:04:56 評論於
8-10 points is already pretty good. As long as it can be maintained at this level for a long time, it will be considered an internationally leading journal
(0) 讚! | 凌霄高洁

首頁    上一頁    1    下一頁    末頁  (頁
/1)

開始撰寫 [CURRENT OPINION IN CELL BIOLOGY] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*